BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Policy

  NPS Pharmaceuticals, Inc. Announces FDA Acceptance Of Biologics License Application For Natpara® For The Treatment Of Hypoparathyroidism

  January 8, 2014

   · 

  1 min read
• BioMidwest

  Myriad Genetics, Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference

  January 8, 2014

   · 

  1 min read
• Genetown

  Aegerion Pharmaceuticals, Inc. Grants Stock Options Under Inducement Program

  January 8, 2014

   · 

  1 min read
• Pluristem Therapeutics Receives Key Placental Cell Therapy Patent in Australia

  January 8, 2014

   · 

  1 min read
• Business

  Jesper Bramming, Former A.P. Moller Executive, Joins The CMC Biologics Executive Management Team As Chief Financial Officer

  January 8, 2014

   · 

  2 min read
• Insight Genetics Awarded New National Cancer Institute Contract To Identify Resistance Mutations In Lung Cancer Patients

  January 8, 2014

   · 

  1 min read
• Business

  Emerald Bio Announces New Partnership To Study Therapeutic Targets In Space

  January 8, 2014

   · 

  4 min read
• New Treasury Shares Of BioTie Therapies Corp. Registered With The Trade Register

  January 8, 2014

   · 

  1 min read
• Drug Development

  CytoDyn Announces FDA Approval Of Patient Screening For Phase 2b Study With Lead Product Candidate PRO 140 For The Treatment Of HIV Type 1

  January 8, 2014

   · 

  1 min read
• Pharm Country

  ERT Reaches Milestone In Supporting Successful New Drug Approvals

  January 8, 2014

   · 

  2 min read